The Lancet Publishes Landmark Trial of Duchenne Muscular Dystrophy Therapy
July 29, 2026
July 29, 2026
LOS ANGELES, California, July 29 [Category: BizHospital] -- Cedars-Sinai, a nonprofit academic healthcare organization, posted the following news:
* * *
The Lancet Publishes Landmark Trial of Duchenne Muscular Dystrophy Therapy
*
An investigational cell therapy preserved heart and muscle function in boys and young men with Duchenne muscular dystrophy, according to Phase III clinical trial results from Cedars-Sinai Health Sciences University inv . . .
* * *
The Lancet Publishes Landmark Trial of Duchenne Muscular Dystrophy Therapy
*
An investigational cell therapy preserved heart and muscle function in boys and young men with Duchenne muscular dystrophy, according to Phase III clinical trial results from Cedars-Sinai Health Sciences University inv . . .